News

Find News

Filter articles

Applied Filters

Showing 861 to 870 of 910 results

India urged to improve its drugs patent policy

India, US30-09-2013

India’s drug patent policy has been slammed by US companies who are insisting that action be taken in order to improve trade relations.

Judge denies AstraZeneca’s bid to squash pay-for-delay challenge

US27-09-2013Legal developments

A federal judge has denied AstraZeneca’s motions to dismiss claims challenging its pay-for-delay deals with three generic pharmaceutical companies in connection to heartburn drug Nexium.

Teva holds on to Azilect exclusivity

US25-09-2013

The US District Court for the District of New Jersey has found in favour of Teva Pharmaceutical Industries Ltd in its patent infringement case with Mylan over Parkinson’s disease drug Azilect.

Ranbaxy receives notice for acne drug generic

US24-09-2013

Drug company Watson Laboratories (Actavis) has notified rival Ranbaxy Laboratories that it has applied to sell a generic version of anti-acne product Absorica in the US.

Austria becomes first country to ratify Unified Patent Court agreement

Austria, EU27-08-2013

Austria has become the first country in the EU to ratify consent to the Unified Patent Court.

Eli Lilly bids to stop generics cutting Alimta exclusivity

US23-08-2013

Eli Lilly has begun its defence of a patent covering lung cancer drug Alimta against generic companies including Teva, Barr Laboratories and APP Pharmaceuticals.

Horizon Pharma settles Duexis case with Par Pharmaceuticals

US22-08-2013Legal developments

US-based Horizon Pharma Inc agreed on August 22 to settle its patent dispute over arthritis drug Duexis with generic maker Par Pharmaceutical Companies.

IPAB revokes Allergan eye drug patent

India12-08-2013Legal developments

On August 8 the IPAB revoked another patent owned by a Western pharmaceutical company – this time related to Allergan’s eye drug Combigan.

IPAB throws out Indian Vega trademarks

India02-08-2013

The Intellectual Property Appellate Board in Chennai has cancelled two trademarks associated with versions of Viagra.

UK Appeals Court upholds Teva’s Copaxone patent

UK01-08-2013Legal developments

The Court of Appeal for England and Wales has upheld the Patent Court’s decision that Teva Pharmaceutical Industries’ UK patent 762,888, relating to the multiple sclerosis drug Copaxone, is valid.

Showing 861 to 870 of 910 results

LSIPR